Trial Profile
A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects With Acute Myeloid Leukemia Who Are 60 Years or Older - The BATTLE Study
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 22 May 2020
Price :
$35
*
At a glance
- Drugs Atezolizumab (Primary) ; Motixafortide (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Acronyms BATTLE
- Sponsors BioLineRx
- 14 May 2020 Status changed from recruiting to discontinued.
- 20 Dec 2019 This trial has been Discontinued in Spain, according to European Clinical Trials Database.
- 05 Dec 2019 This trial has been Discontinued in Hungary, according to European Clinical Trials Database.